Literature DB >> 9143967

The management of bone defects in revision total knee arthroplasty.

G A Engh1, N L Parks.   

Abstract

The number of failed total knees with large bone defects is increasing. This is related to the large number of total knee arthroplasty procedures that are being performed in an increasingly active patient population. Long-term results are needed to compare clinical outcome and survivorship of allograft reconstruction versus custom prosthetic components. A benefit to using allograft reconstruction is that the bone deficiency is not increased as occurs with custom devices, and may be decreased with incorporation of the graft. In our current economic climate there are advantages to using allografts, despite costs as high as $1,600 for processing of a proximal or distal femur. In comparison, custom prostheses are not as cost effective. A material that can unite and gradually incorporate with host bone increases the potential for long-term success. Allograft may be used as part of a reconstructive armamentarium for total knee arthroplasty. Allografts are not implants and must be used as physiologic material. The early results are comparable or superior to traditional methods of reconstruction. The augmented bone stock in allograft knees remains a theoretical advantage and may facilitate subsequent revisions.

Entities:  

Mesh:

Year:  1997        PMID: 9143967

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  26 in total

1.  Level of constraint in revision knee arthroplasty.

Authors:  Pier Francesco Indelli; Nick Giori; William Maloney
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

2.  The role of offset stems in revision knee arthroplasty.

Authors:  Andrea Baldini; Giovanni Balato; Vincenzo Franceschini
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

3.  Management of the bone loss by metaphyseal sleeves in primary and revision knee arthroplasty: clinical experience and outcome after forty three cases.

Authors:  Usman Nazir Gill; Nasir Ahmed; Syed Shahid Noor; Iftikhar Ahmed Memon; Zulfiqar Ali Memon
Journal:  Int Orthop       Date:  2020-06-17       Impact factor: 3.075

4.  [Defect Reconstruction in Total Knee Arthroplasty with wedges and blocks]. [Corrected].

Authors:  R Hube; T Pfitzner; P von Roth; H O Mayr
Journal:  Oper Orthop Traumatol       Date:  2015-02-04       Impact factor: 1.154

5.  Does knee revision after an articulated spacer implant provide normal gait restoration?

Authors:  Nicola Logoluso; Alice Nardo; Federica Anasetti; Sara Scarponi; Carlo Luca Romanò
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-10-19       Impact factor: 4.342

6.  Metaphyseal cones and sleeves in revision total knee arthroplasty: Two sides of the same coin? Complications, clinical and radiological results-a systematic review of the literature.

Authors:  A Zanirato; M Formica; L Cavagnaro; S Divano; G Burastero; L Felli
Journal:  Musculoskelet Surg       Date:  2019-03-16

7.  CT Lesion Model-Based Structural Allografts: Custom Fabrication and Clinical Experience.

Authors:  Jan Claas Brune; Uwe Hesselbarth; Philipp Seifert; Dimitri Nowack; Rüdiger von Versen; Mark David Smith; Dirk Seifert
Journal:  Transfus Med Hemother       Date:  2012-11-13       Impact factor: 3.747

8.  Articulated spacer provides long-term knee improvement after two-stage reimplantation.

Authors:  Michele Vasso; Chiara Del Regno; Katia Corona; Rocco D'Apolito; Alfredo Schiavone Panni
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-07-11       Impact factor: 4.342

9.  Revision total knee arthroplasty with varus-valgus constrained prosthesis versus posterior stabilized prosthesis.

Authors:  Joon Kyu Lee; Sahnghoon Lee; Dongwook Kim; Sang Min Lee; Jak Jang; Sang Cheol Seong; Myung Chul Lee
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-04-08       Impact factor: 4.342

10.  Two-stage treatment of infected total knee arthroplasty: two to thirteen year experience using an articulating preformed spacer.

Authors:  Claudio Carlo Castelli; Valerio Gotti; Roberto Ferrari
Journal:  Int Orthop       Date:  2014-01-26       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.